165 filings
Page 5 of 9
8-K
jb04msypenwog
25 Oct 19
AbbVie Announces Commencement of Exchange Offers and Consent Solicitations for Allergan Notes
8:25am
8-K
utmljtc46r1mvouh
22 Oct 19
Amendments to Articles of Incorporation or Bylaws
4:41pm
8-K
51x04uq9m
26 Sep 19
Entry into a Material Definitive Agreement
4:06pm
8-K
7kbgo7e
23 Sep 19
Entry into a Material Definitive Agreement
4:24pm
8-K
dzp3u9bcwqu9
16 Sep 19
Regulation FD Disclosure
7:57am
8-K
ktcoam517hl 5c
16 Sep 19
Index to Consolidated Financial Statements
6:08am
8-K
f1xz6c ewos3zmt
30 Aug 19
Entry into a Material Definitive Agreement
4:19pm
8-K
n6v vzpgsppb7k8s7xf
26 Jul 19
AbbVie Reports Second-Quarter 2019 Financial Results
7:44am
8-K
t9z0bu4m0a
16 Jul 19
Entry into a Material Definitive Agreement
4:43pm
8-K
wq2fj 1jxmj
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm
8-K
fqv1tudf r3c
6 May 19
Submission of Matters to a Vote of Security Holders
5:12pm
8-K
i2gw6wv5 o7iovoj
25 Apr 19
AbbVie Reports First-Quarter 2019 Financial Results
7:45am
8-K
75k1icmbqu5 6tasp
25 Jan 19
AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results
7:46am
8-K
daj285u9bkylyoh
4 Jan 19
Departure of Directors or Certain Officers
5:02pm
8-K
rdhoz5xnt61la2ojgp
4 Jan 19
Material Impairments
5:00pm
8-K
iw78f1rit2 rzxqdb
17 Dec 18
AbbVie Announces Executive Leadership Changes
9:10am
8-K
jw7ijmrwan5okdyh azs
2 Nov 18
AbbVie Reports Third-Quarter 2018 Financial Results
7:50am
8-K
2f1tl072uorez
19 Oct 18
Departure of Directors or Certain Officers
9:00am
8-K
gceb5 4oh5sq01c
18 Sep 18
Entry into a Material Definitive Agreement
12:00am
8-K
0tq9u0djt w38
6 Sep 18
Entry into a Material Definitive Agreement
12:00am